On Sept. 24, 2021, Moderna announced a supply agreement with the government of Peru for 20 million doses of Moderna’s COVID-19 vaccine to begin delivery in the first quarter of 2022.

Moderna said it will work with the regulators in the country to pursue necessary approvals prior to distribution of its vaccine, which is not currently approved for use in Peru. The country has so far vaccinated about 37.6% of its population, according to the latest Reuters tally.

There have been 2,169,427 infections and 199,108 coronavirus-related deaths reported in Peru since the pandemic began, according to a Reuters tally. In June, the Biden administration said it was shipping 2 million doses of the Pfizer COVID-19 vaccine to Peru.